Organisation: Federal Commission for Protection against Sanitary Risks (Mexico)

Mexico: regulatory certainty for biosimilars on the horizon

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

The challenges that innovators face when enforcing and defending their rights depend on how developed the regulatory framework is, and the courts’ approach to patent cases. Against this backdrop, the biosimilar industry is tackling regulatory uncertainties and Mexico's 2024 elections could prove pivotal when it comes to developing a strategy to combat these issues. 

24 June 2024

Unlock unlimited access to all IAM content